Skip to Content

Shandong Guobang Pharmaceutical, China, 2023

GMP Audit Report

Company
Shandong Guobang Pharmaceutical

Product(s)
Florfenicol

Country
China

Audit Year
2023

0.00 € 0.00 €
0.00 €